MARTHA GUZMAN: Open Payments
NPI 1538875059 · LINDSAY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 17 payments from 8 companies in 2025. Trend: 2023 $378 · 2024 $793 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $162 |
| Philips North America LLC | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Antares Pharma, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $14 |
Products named: Vest Therapy Und, GEMTESA, FARXIGA, MOUNJARO, ZEPBOUND, XYOSTED, Kerendia, BREZTRI.
Industry payments across CA — which companies pay providers there.
